America’s Long-Term Care Pharmacies Take Action Against COVID-19
SCPC is providing real-time status reports and information regarding LTCP-specific regulatory, legislative and news developments to help our membership navigate important and pressing issues as the COVID-19 pandemic continues to unfold at a rapid pace.
Our members serve more than 850,000 people every day in the nation’s nursing homes and other LTC facilities. Seniors living in congregate settings of this nature are among those most vulnerable to COVID-19. LTC pharmacies are working overtime to protect patients while maintaining continuity and access to critical, life-saving pharmacy services.
Here are the latest developments from SCPC as we help our members fulfill their commitment to serve patients, protect staff and fight back against this deadly virus.
Latest News & Press Releases
- SCPC Praises CMS Guidance Relaxing Face to Face Signature Requirement for LTC Pharmacy Medication Delivery to Nursing Homes
Our response to CMS March 19 guidance to prescription drug plans and pharmacy benefit managers (PDPs/PBMs) urging relaxation of face to face signature requirements for long-term care (LTC) pharmacy delivery of medication to nursing homes.
SCPC request that the National Association of Boards of Pharmacy (NABP) issue a recommendation and guidance urging state Boards of Pharmacy to permit interstate practice of pharmacy in response to the COVID-19 pandemic. While some state boards have acted to relax restrictions in the best interest of patients, various state boards have informed SCPC members that they are awaiting guidance from NABP on this important issue.
A follow-up request for information concerning the timing of any expected responses to SCPC concerns while the situation across the health care delivery system worsens daily, but both nursing homes and LTC pharmacies are in an especially deepening crisis.
Update to SCPC membership on a request to CMS, practice of pharmacy across state lines and availability and access to chloroquine & hydroxychloroquine.
Update to SCPC membership on Part D guidance on signature requirement for drug delivery or dispensing.
Update to SCPC membership on requested relief from PDP/PBM administrative requirements, the Families First Coronavirus Response Act and additional crisis response legislation.
Letter to CMS outlining problems with various PDP administrative requirements that present greater than necessary risk of exposure to COVID-19 for nursing home patients and staff, and pharmacy staff.
Update to SCPC membership on H.R. 6201 as amended March 16, including the Emergency Paid Sick Leave Act and SCPC engagement and next steps.
Update to SCPC membership with current information concerning LTC facilities/nursing homes and SCPC member areas of concern.